- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
- CSICON 2021
- Health Dialogues
- Health News Today
- Health Shorts MDTV
- Hemorrhoids Interventions with Dr Kamal Gupta
- JBCPL - BOK (Body of Knowledge)
- MD Shorts
- Medical News Today
- Medico Legal Update
- Top Videos
- Diabetes Symposium
- Health Perspectives
- Medical Dialogues Show
- Pharma Dialogues
- Rare Disease Show
- Scientific Scholar
Health Shorts MDTV - Page 158
CDSCO panel nod to Novartis Ruxolitinib for acute and chronic graft...
In response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the...
NEET question paper mix up: Health Minister agrees to re-exam at...
As some discrepancies were found during the conduct of NEET 2022 examination held at Army Public School in Sriganganagar...
Health ministry directs all Central govt hospitals to go paperless
The Ministry of Health has directed all Central government hospitals to go paperless. As per the official source,...
Govt launches 3 schemes for MSMEs in pharma sector
The government on Thursday launched three schemes to strengthen Micro, Small and Medium Enterprises (MSMEs) in the...
Zydus gets USFDA nod for blood pressure injection
Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited), has announced that the company has received...
NEET candidates demand 2nd attempt at exam
Although the National Testing Agency (NTA) successfully conducted the National Eligibility-cum-Entrance Test (NEET) 2022...
NMC directs State Medical Councils to appoint officers for taking...
Posing a threat to the sanctity of the medical profession and at the same time diabolically playing with the lives of...
Union health secretary Rajesh Bhushan gets additional charge of...
The Central Government has given the additional charge of the post of Secretary, Department of Health Research, Ministry...
2 junior doctor groups of Almora Medical College get into brawl, probe...
Two groups of junior doctors of orthopaedic and surgery departments working at the Almora Medical College have...
Govt agrees to reinstitute Dr B C Roy Memorial Award for doctors
Bringing good news to the medical fraternity in India, the Union Ministry of Health and Family Welfare has agreed to...
Covaxin booster dose increases immune response by 40 times: Bharat...
Bharat Biotech International Limited (BBIL), has announced that BBV152 (COVAXIN), its whole-virion inactivated COVID-19...
Merck Keytruda fails head and neck cancer trial
Merck, known as MSD outside the United States and Canada, has announced that the Phase 3 KEYNOTE-412 trial evaluating...